
<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>HS Top 200 | Development of immuno-oncology drugs — from ctla4 to pd1 to the next generations, development of immuno-oncology drugs - from ctla4 to pd1 to the next generations | Activity</title>
	<link>https://hstop200.com/members/immunebooster7146723/activity/</link>
	<atom:link href="https://hstop200.com/members/immunebooster7146723/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Development of immuno-oncology drugs — from ctla4 to pd1 to the next generations, development of immuno-oncology drugs - from ctla4 to pd1 to the next generations.</description>
	<lastBuildDate>Tue, 05 May 2026 10:35:05 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-NZ</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">b045c32f57dfce60a7a7a30675746c65</guid>
				<title>Development of immuno-oncology drugs — from ctla4 to pd1 to the next generations, development of immuno-oncology drugs - from ctla4 to pd1 to the next generations posted an update: CLICK HERE &#062;&#062;&#062; Development of immuno-oncology drugs — from c [&#133;]</title>
				<link>https://hstop200.com/activity/p/28722/</link>
				<pubDate>Mon, 23 Nov 2020 08:22:38 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>CLICK HERE &gt;&gt;&gt; </b><b><a href="https://immune20.tdska.org/immunebooster1-a.html" rel="nofollow ugc">Development of immuno-oncology drugs — from ctla4 to pd1 to the next generations, development of immuno-oncology drugs &#8211; from ctla4 to pd1 to the next generations &#8211; Immune system supplements</a></b>&nbsp;<br />
&nbsp;</p>
<p>   &nbsp;<br />
&nbsp;</p>
<p>   &nbsp;<br />
&nbsp;</p>
<p>   &nbsp;<br />
&nbsp;</p>
<p>   &nbsp;<br />
&nbsp;</p>
<p>   &nbsp;<br />
&nbsp;</p>
<p>   &nbsp;<br />
&nbsp;</p>
<p>  &nbsp;<br />
&nbsp;<br />
&nbsp;<br />
&nbsp;<br />
&nbsp;<br />
&nbsp;<br />
&nbsp;<br />
&nbsp;<br />
&nbsp;<br />
&nbsp;<br />
&nbsp;<br />
&nbsp;<br />
&nbsp;<br />
&nbsp;<br />
&nbsp;<br />
&nbsp;<br />
&nbsp;<br />
&nbsp;<br />
&nbsp;<br />
&nbsp;<br />
&nbsp;<br />
&nbsp;<br />
&nbsp;<br />
&nbsp;<br />
&nbsp;<br />
&nbsp;<br />
&nbsp;<br />
&nbsp;</p>
<p>  &#038;&hellip;<span class="activity-read-more" id="activity-read-more-28722"><a href="https://hstop200.com/activity/p/28722/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">da51a0d0fa2402c6ce5904a4932ffe48</guid>
				<title>Development of immuno-oncology drugs — from ctla4 to pd1 to the next generations, development of immuno-oncology drugs - from ctla4 to pd1 to the next generations&#039;s profile was updated</title>
				<link>https://hstop200.com/activity/p/28721/</link>
				<pubDate>Mon, 23 Nov 2020 08:22:30 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">923c3557aa0b2010b8239b0c3fd7cc4c</guid>
				<title>Development of immuno-oncology drugs — from ctla4 to pd1 to the next generations, development of immuno-oncology drugs - from ctla4 to pd1 to the next generations became a registered member</title>
				<link>https://hstop200.com/activity/p/28719/</link>
				<pubDate>Mon, 23 Nov 2020 08:22:17 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>